Protocols
2 protocol(s) meet the specified criteria
Drug: NAB PACLITAXEL
Protocol No.TitleStatus
LCCC1210Tolerability of weekly nab-paclitaxel as second line treatment for elderly patients with advanced lung cancerOpen
LCCC1516A Randomized, Non-comparative Three Arm Phase II Trial of Sequential Consolidation with Pembrolizumab followed by Nab-paclitaxel, Sequential Consolidation with Nab-paclitaxel followed by Pembrolizumab and Concurrent Consolidation with Nab-paclitaxel and Pembrolizumab after Standard First-Line Induction Chemotherapy in Advanced NSCLCOpen